{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:59:11Z","timestamp":1785308351421,"version":"3.55.0"},"reference-count":135,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jhepr.2024.101265","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T20:33:42Z","timestamp":1731443622000},"page":"101265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Quo vadis autoimmune hepatitis? - Summary of the 5th international autoimmune hepatitis group research workshop 2024"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0972-3454","authenticated-orcid":false,"given":"Bastian","family":"Engel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Assis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamatha","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Clusmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost PH.","family":"Drenth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5086-0514","authenticated-orcid":false,"given":"Alessio","family":"Gerussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda-Carlota","family":"Londo\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye Htun","family":"Oo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Schregel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5163-6979","authenticated-orcid":false,"given":"Marcial","family":"Sebode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9270-2496","authenticated-orcid":false,"given":"Richard","family":"Taubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2024.101265_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102280","article-title":"Global incidence and prevalence of autoimmune hepatitis, 1970\u20132022: a systematic review and meta-analysis","volume":"65","author":"Hahn","year":"2023","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.jhepr.2024.101265_bib2","article-title":"Population-based study of autoimmune hepatitis and primary biliary cholangitis in Germany: rising prevalences based on ICD codes, yet deficits in medical treatment","author":"Sebode","year":"2020","journal-title":"Z\u00a0Gastroenterol"},{"key":"10.1016\/j.jhepr.2024.101265_bib3","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jhep.2013.10.020","article-title":"Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study","volume":"60","author":"Gr\u00f8nb\u00e6k","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2024.101265_bib4","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jhep.2013.10.035","article-title":"Health-related quality of life, depression, and anxiety in patients with autoimmune hepatitis","volume":"60","author":"Schramm","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2024.101265_bib5","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.4254\/wjh.v13.i11.1642","article-title":"Health-related quality of life in autoimmune hepatitis","volume":"13","author":"Snijders","year":"2021","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jhepr.2024.101265_bib6","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/HEP.0000000000000589","article-title":"Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: first report of the IAIHG retrospective registry","volume":"79","author":"Slooter","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2024.101265_bib7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jhep.2024.03.021","article-title":"Treatment response and clinical event-free survival in autoimmune hepatitis: a Canadian multicentre cohort study","volume":"81","author":"Plagiannakos","year":"2024","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2024.101265_bib8","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/liv.15573","article-title":"Research gaps and opportunities in autoimmune hepatitis\u2014results of the international autoimmune hepatitis group research workshop 2022","volume":"43","author":"Snijders","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2024.101265_bib9","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/apt.15111","article-title":"Review article: unanswered clinical and research questions in autoimmune hepatitis-conclusions of the International Autoimmune Hepatitis Group Research Workshop","volume":"49","author":"Dyson","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2024.101265_bib10","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.1840180435","article-title":"Meeting report: international autoimmune hepatitis group","volume":"18","author":"Johnson","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2024.101265_bib11","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2024.101265_bib12","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0168-8278(99)80342-0","article-title":"Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis","volume":"31","author":"Kanzler","year":"1999","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2024.101265_bib13","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.jhep.2007.05.011","article-title":"The significance of autoantibodies and immunoglobulins in acute liver failure: a cohort study","volume":"47","author":"Bernal","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2024.101265_bib14","article-title":"Features and outcome of AIH patients without elevation of IgG","volume":"2","author":"Hartl","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2024.101265_bib15","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/hep.24080","article-title":"Autoimmune acute liver failure: proposed clinical and histological criteria","volume":"53","author":"Stravitz","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2024.101265_bib16","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s00535-010-0316-3","article-title":"Clinicopathological features of severe and fulminant forms of autoimmune hepatitis","volume":"46","author":"Yasui","year":"2011","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.jhepr.2024.101265_bib17","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.cgh.2006.10.011","article-title":"Clinicopathologic features of the severe form of acute type 1 autoimmune hepatitis","volume":"5","author":"Abe","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2024.101265_bib18","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1136\/jcp.2005.029348","article-title":"Centrilobular necrosis in autoimmune hepatitis: a histological feature associated with acute clinical presentation","volume":"59","author":"Hofer","year":"2006","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.jhepr.2024.101265_bib19","article-title":"Approach to the patient with acute severe autoimmune hepatitis","volume":"2","author":"Rahim","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2024.101265_bib20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2024.101265_bib21","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jhep.2020.07.032","article-title":"Update of the simplified criteria for autoimmune hepatitis: evaluation of the methodology for immunoserological testing","volume":"74","author":"Galaski","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2024.101265_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-37095-z","article-title":"Evaluation of immunoserological detection of anti-liver kidney microsomal, anti-soluble liver antigen and anti-mitochondrial antibodies","volume":"13","author":"Campos-Murguia","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2024.101265_bib23","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jhep.2004.08.002","article-title":"Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group","volume":"41","author":"Vergani","year":"2004","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2024.101265_bib24","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1023\/B:DDAS.0000004522.36120.08","article-title":"Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: prevalence and correlates","volume":"48","author":"Loria","year":"2003","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhepr.2024.101265_bib25","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1007\/s12072-024-10695-1","article-title":"Detection of polyreactive immunoglobulin G facilitates diagnosis in children with autoimmune hepatitis","volume":"18","author":"Engel","year":"2024","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhepr.2024.101265_bib26","author":"Kirchner"},{"key":"10.1016\/j.jhepr.2024.101265_bib27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/hep.32134","article-title":"Quantification of polyreactive immunoglobulin G facilitates the diagnosis of autoimmune hepatitis","volume":"75","author":"Taubert","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2024.101265_bib28","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","article-title":"Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy: primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy","volume":"28","author":"Chazouill\u00e8res","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2024.101265_bib29","article-title":"Diagnostic criteria and long-term outcomes in AIH-PBC variant syndrome under combination therapy","volume":"6","author":"Stoelinga","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2024.101265_bib30","first-page":"1449","article-title":"Treatment of overlap\u00a0syndromes in autoimmune liver disease: a systematic review and meta-analysis","volume":"9","author":"Freedman","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jhepr.2024.101265_bib31","article-title":"Meta-analysis: diagnostic accuracy of antinuclear antibodies, smooth muscle antibodies and antibodies to a soluble liver antigen\/liver pancreas in autoimmune hepatitis","author":"Zhang","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jhepr.2024.101265_bib32","first-page":"686","article-title":"Prevalence and clinical significance of portal inflammation, portal plasma cells, interface hepatitis and biliary injury in liver biopsies from patients with non-alcoholic steatohepatitis","volume":"54","author":"Dhingra","year":"2022","journal-title":"Pathology (Phila)"},{"key":"10.1016\/j.jhepr.2024.101265_bib33","article-title":"Treatment responses and outcomes in patients with autoimmune hepatitis and concomitant features of non-alcoholic fatty liver disease","volume":"5","author":"Zachou","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2024.101265_bib34","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1007\/s10620-016-4213-3","article-title":"Natural history of patients presenting with autoimmune hepatitis and coincident nonalcoholic fatty liver disease","volume":"61","author":"De Luca-Johnson","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhepr.2024.101265_bib35","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jhep.2023.04.033","article-title":"Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): an expert opinion meeting report","volume":"79","author":"Andrade","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2024.101265_bib36","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/ueg2.12499","article-title":"Defining characteristics and long-term prognosis of drug-induced autoimmune-like hepatitis: a retrospective cohort study","volume":"12","author":"Chung","year":"2024","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.jhepr.2024.101265_bib37","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the study of liver diseases","author":"Mack","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2024.101265_bib38","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","author":"Lohse","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2024.101265_bib39","doi-asserted-by":"crossref","DOI":"10.1097\/HEP.0000000000000940","article-title":"Optimizing thiopurine therapy in autoimmune hepatitis: a multi-center study on monitoring metabolite profiles and co-therapy with allopurinol","author":"Weltzsch","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2024.101265_bib40","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/apt.17831","article-title":"Clinical trial: combination allopurinol-thiopurine versus standard thiopurine in patients with IBD escalating to immunomodulators (the DECIDER study)","volume":"59","author":"Vasudevan","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2024.101265_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101332","article-title":"Low-dose azathioprine and allopurinol versus azathioprine monotherapy in patients with ulcerative colitis (AAUC): an investigator-initiated, open, multicenter, parallel-arm, randomised controlled trial","volume":"45","author":"Kiszka-Kanowitz","year":"2022","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.jhepr.2024.101265_bib42","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1080\/00365521.2024.2323502","article-title":"Efficacy of optimised thiopurine therapy in patients with moderate-to-severe ulcerative colitis: retrospective long-term follow-up from two randomised trials","volume":"59","author":"Mertz Nielsen","year":"2024","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhepr.2024.101265_bib43","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1053\/j.gastro.2010.06.046","article-title":"Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis","volume":"139","author":"Manns","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2024.101265_bib44","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/HEP.0000000000000018","article-title":"Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration","volume":"77","author":"D\u00edaz-Gonz\u00e1lez","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2024.101265_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2020.07.023","article-title":"Second-line and third-line therapy for autoimmune hepatitis: a position statement from the European reference network on hepatological diseases and the international autoimmune hepatitis group","author":"Lohse","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2024.101265_bib46","article-title":"Long-term results of mycophenolate mofetil vs. azathioprine use in individuals with autoimmune hepatitis","volume":"4","author":"Dalekos","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2024.101265_bib47","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jhep.2023.11.032","article-title":"An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis","volume":"80","author":"Snijders","year":"2024","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2024.101265_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2019.10.005","article-title":"Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: results from the international autoimmune hepatitis group","author":"Than","year":"2019","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2024.101265_bib49","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1111\/liv.15970","article-title":"Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis: results from the ColHai registry","volume":"44","author":"Riveiro-Barciela","year":"2024","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2024.101265_bib50","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/ajt.12220","article-title":"A\u00a0single dose of rituximab does not deplete B cells in secondary lymphoid organs but alters phenotype and function","volume":"13","author":"Kamburova","year":"2013","journal-title":"Am J Transpl"},{"key":"10.1016\/j.jhepr.2024.101265_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103113","article-title":"Hepatic safety and efficacy of immunomodulatory drugs used in patients with autoimmune hepatitis","volume":"140","author":"Terziroli Beretta-Piccoli","year":"2023","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jhepr.2024.101265_bib52","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1038\/s41591-024-02964-1","article-title":"Bispecific T cell engager therapy for refractory rheumatoid arthritis","volume":"30","author":"Bucci","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.jhepr.2024.101265_bib53","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/s41591-022-02017-5","article-title":"Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus","volume":"28","author":"Mackensen","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.jhepr.2024.101265_bib54","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa2308917","article-title":"CD19 CAR T-cell therapy in autoimmune disease \u2014 a case series with follow-up","volume":"390","author":"M\u00fcller","year":"2024","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhepr.2024.101265_bib55","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S1474-4422(24)00140-6","article-title":"B\u00a0cell-targeting chimeric antigen receptor T cells as an emerging therapy in neuroimmunological diseases","volume":"23","author":"Haghikia","year":"2024","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jhepr.2024.101265_bib56","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1056\/NEJMc2408786","article-title":"BCMA-targeted T-cell\u2013engager therapy for autoimmune disease","volume":"391","author":"Hagen","year":"2024","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhepr.2024.101265_bib57","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.jpeds.2013.05.042","article-title":"Budesonide versus prednisone with azathioprine for the treatment of autoimmune hepatitis in children and adolescents","volume":"163","author":"Woynarowski","year":"2013","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jhepr.2024.101265_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2019.08.001","article-title":"Liver homing of clinical grade Tregs after therapeutic infusion in patients with autoimmune hepatitis","author":"Oo","year":"2019","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2024.101265_bib59","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/gutjnl-2022-327075","article-title":"Autologous regulatory T-cell transfer in refractory ulcerative colitis with concomitant primary sclerosing cholangitis","volume":"72","author":"Voskens","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2024.101265_bib60","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1002\/hep.30059","article-title":"Low-dose interleukin-2 for refractory autoimmune hepatitis","volume":"68","author":"Lim","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2024.101265_bib61","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jhep.2022.08.035","article-title":"Low dose interleukin-2 selectively expands circulating regulatory T cells but fails to promote liver allograft tolerance in humans","volume":"78","author":"Lim","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2024.101265_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002139","article-title":"Regulatory T cell responses in participants with type 1 diabetes after a single dose of interleukin-2: a non-randomised, open label, adaptive dose-finding trial","volume":"13","author":"Todd","year":"2016","journal-title":"PLOS Med"},{"key":"10.1016\/j.jhepr.2024.101265_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.05.017","article-title":"Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes","author":"Tenspolde","year":"2019","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jhepr.2024.101265_bib64","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/ajt.14175","article-title":"Prevention of allograft rejection by use of regulatory T cells with an MHC-specific chimeric antigen receptor","volume":"17","author":"Noyan","year":"2017","journal-title":"Am J Transpl"},{"key":"10.1016\/j.jhepr.2024.101265_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103057","article-title":"Supraphysiological FOXP3 expression in human CAR-Tregs results in improved stability, efficacy, and safety of CAR-Treg products for clinical application","volume":"138","author":"Henschel","year":"2023","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jhepr.2024.101265_bib66","author":"Spanier"},{"key":"10.1016\/j.jhepr.2024.101265_bib67","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/ajt.14185","article-title":"Expression of a chimeric antigen receptor specific for donor HLA class I enhances the potency of human regulatory T cells in preventing human skin transplant rejection","volume":"17","author":"Boardman","year":"2017","journal-title":"Am J Transpl"},{"key":"10.1016\/j.jhepr.2024.101265_bib68","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1172\/JCI82771","article-title":"Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor","volume":"126","author":"MacDonald","year":"2016","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhepr.2024.101265_bib69","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S2468-1253(18)30043-8","article-title":"Unmet needs and new models for future trials in autoimmune hepatitis","volume":"3","author":"Jones","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2024.101265_bib70","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s12072-023-10482-4","article-title":"Identifying the early predictors of non-response to steroids in patients with flare of autoimmune hepatitis causing acute-on-chronic liver failure","volume":"17","author":"Sharma","year":"2023","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhepr.2024.101265_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2023.01.013","article-title":"Long-term outcomes of patients with type 1 or 2 autoimmune hepatitis presenting in childhood","author":"Maggiore","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2024.101265_bib72","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/liv.15440","article-title":"Confidence in treatment is contributing to quality of life in autoimmune liver diseases. The results of ERN RARE-LIVER online survey","volume":"43","author":"Wunsch","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2024.101265_bib73","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/liv.15552","article-title":"Long-term outcome of liver transplantation for autoimmune hepatitis: a French nationwide study over 30 years","volume":"43","author":"Chouik","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2024.101265_bib74","article-title":"Unmet needs in autoimmune hepatitis: results of the prospective multicentre European Reference Network Registry (R-LIVER)","volume":"liv","author":"Schregel","year":"2024","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2024.101265_bib75","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10620-022-07525-5","article-title":"Patient priorities in autoimmune hepatitis: the need for better treatments, more education and challenging stigma","volume":"68","author":"Lloyd","year":"2023","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhepr.2024.101265_bib76","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/hep.30031","article-title":"The impact of autoimmune hepatitis and its treatment on health utility","volume":"68","author":"Wong","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2024.101265_bib77","doi-asserted-by":"crossref","DOI":"10.1097\/HEP.0000000000001089","article-title":"Efficacy and safety of infliximab in patients with autoimmune hepatitis","author":"Efe","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2024.101265_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2012.11.010","article-title":"Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis","author":"Weiler-Normann","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2024.101265_bib79","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13063-023-07832-w","article-title":"Tacrolimus versus mycophenolate for AutoImmune hepatitis patients with incompLete response on first-line therapy (TAILOR study): a study protocol for a phase III, open-label, multicentre, randomised controlled trial","volume":"25","author":"Stoelinga","year":"2024","journal-title":"Trials"},{"key":"10.1016\/j.jhepr.2024.101265_bib80","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000458","article-title":"Autoimmune hepatitis: current and future therapies","volume":"8","author":"Reau","year":"2024","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhepr.2024.101265_bib81","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-080143","article-title":"Protocol for the development of a\u00a0core outcome set for clinical trials in primary sclerosing cholangitis","volume":"14","author":"Hussain","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.jhepr.2024.101265_bib82","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s12072-021-10170-1","article-title":"The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis","volume":"15","author":"Wang","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhepr.2024.101265_bib83","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jhep.2021.12.041","article-title":"Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group","volume":"76","author":"Pape","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2024.101265_bib84","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/ajg.2015.139","article-title":"Long-term prognostic significance of persisting histological activity despite biochemical remission in autoimmune hepatitis","volume":"110","author":"Dhaliwal","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2024.101265_bib85","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/j.cgh.2021.05.024","article-title":"Aminotransferases during treatment predict long-term survival in patients with autoimmune hepatitis type 1: a landmark analysis","volume":"20","author":"Biewenga","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2024.101265_bib86","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1111\/liv.15241","article-title":"Treatment and outcome of autoimmune hepatitis: audit of 28 UK centres","volume":"42","author":"Gordon","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2024.101265_bib87","article-title":"Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis","volume":"3","author":"Laschtowitz","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2024.101265_bib88","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/liv.13960","article-title":"Autoimmune hepatitis exerts a profound, negative effect on health-related quality of life: a prospective, single-centre study","volume":"39","author":"Janik","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2024.101265_bib89","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s00795-024-00380-5","article-title":"Characteristics of peripheral blood mononuclear cells and potential related molecular mechanisms in patients with autoimmune hepatitis: a single-cell RNA sequencing analysis","volume":"57","author":"Abe","year":"2024","journal-title":"Med Mol Morphol"},{"key":"10.1016\/j.jhepr.2024.101265_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2020.05.053","article-title":"Integrative molecular profiling of autoreactive CD4 T cells in autoimmune hepatitis","author":"Renand","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2024.101265_bib91","article-title":"Next-generation immunosequencing reveals pathological T cell architecture in autoimmune hepatitis","author":"Schulthei\u00df","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2024.101265_bib92","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jhep.2012.04.005","article-title":"Regulatory T cells and autoimmune hepatitis: defective cells or a hostile environment?","volume":"57","author":"Oo","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2024.101265_bib93","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jhep.2014.08.005","article-title":"Regulatory T cells and autoimmune hepatitis: what happens in the liver stays in the liver","volume":"61","author":"Oo","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2024.101265_bib94","doi-asserted-by":"crossref","first-page":"S293","DOI":"10.1016\/S0168-8278(24)01050-X","article-title":"SAT-153-YI Single-cell RNA sequencing identifies the fundamental role of intrahepatic CD8+ T cells in the pathogenesis of autoimmune hepatitis","volume":"80","author":"Olivas","year":"2024","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2024.101265_bib95","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/MPG.0000000000003353","article-title":"Examining the hepatic immune system in children with liver disease with fine needle aspiration","volume":"74","author":"Yuksel","year":"2022","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhepr.2024.101265_bib96","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.jhep.2012.07.008","article-title":"CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liver","volume":"57","author":"Oo","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2024.101265_bib97","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.4049\/jimmunol.0901216","article-title":"Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver","volume":"184","author":"Oo","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jhepr.2024.101265_bib98","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12920-024-01796-9","article-title":"A\u00a0systematic analysis of deep learning in genomics and histopathology for precision oncology","volume":"17","author":"Unger","year":"2024","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.jhepr.2024.101265_bib99","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jhep.2023.01.006","article-title":"Artificial intelligence, machine learning, and deep learning in liver transplantation","volume":"78","author":"Bhat","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2024.101265_bib100","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/s41591-023-02332-5","article-title":"A\u00a0deep learning algorithm to predict risk of pancreatic cancer from disease trajectories","volume":"29","author":"Placido","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.jhepr.2024.101265_bib101","doi-asserted-by":"crossref","unstructured":"Gerussi A, Saldanha OL, Cazzaniga G, et\u00a0al. Deep Learning helps discriminating Autoimmune Hepatitis and Primary Biliary Cholangitis. JHEP Rep n.d https:\/\/doi.org\/10.1016\/j.jhepr.2024.101198.","DOI":"10.1016\/j.jhepr.2024.101198"},{"key":"10.1016\/j.jhepr.2024.101265_bib102","article-title":"Evaluation of four chatbots in autoimmune liver disease: a comparative analysis","volume":"30","author":"Daza","year":"2024","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jhepr.2024.101265_bib103","doi-asserted-by":"crossref","DOI":"10.1056\/AIcs2300235","article-title":"GPT-4 for information retrieval and comparison of medical oncology guidelines","volume":"1","author":"Ferber","year":"2024","journal-title":"NEJM AI"},{"key":"10.1016\/j.jhepr.2024.101265_bib104","article-title":"External validation of the IAIHG autoimmune hepatitis response criteria in a multicentric real-world cohort","volume":"6","author":"Grossar","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2024.101265_bib105","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/liv.15141","article-title":"Machine learning in primary biliary cholangitis: a novel approach for risk stratification","volume":"42","author":"Gerussi","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2024.101265_bib106","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/s41591-022-01768-5","article-title":"Swarm learning for decentralized artificial intelligence in cancer histopathology","volume":"28","author":"Saldanha","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.jhepr.2024.101265_bib107","doi-asserted-by":"crossref","first-page":"8290","DOI":"10.1038\/s41467-023-43749-3","article-title":"Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma","volume":"14","author":"Calderaro","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhepr.2024.101265_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/S2589-7500(23)00068-7","article-title":"A\u00a0deep learning framework for personalised dynamic diagnosis of graft fibrosis after liver transplantation: a retrospective, single Canadian centre, longitudinal study","author":"Azhie","year":"2023","journal-title":"Lancet Digit Health"},{"key":"10.1016\/j.jhepr.2024.101265_bib109","doi-asserted-by":"crossref","first-page":"e295","DOI":"10.1016\/S2589-7500(21)00040-6","article-title":"Long-term mortality risk stratification of liver transplant recipients: real-time application of deep learning algorithms on longitudinal data","volume":"3","author":"Nitski","year":"2021","journal-title":"Lancet Digit Health"},{"key":"10.1016\/j.jhepr.2024.101265_bib110","article-title":"Clinical deployment of machine learning tools in transplant medicine: what does the future hold?","author":"Rabindranath","year":"2023","journal-title":"Transplantation"},{"key":"10.1016\/j.jhepr.2024.101265_bib111","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13023-023-02667-9","article-title":"Barriers and facilitators to the implementation of guidelines in rare diseases: a systematic review","volume":"18","author":"Gittus","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jhepr.2024.101265_bib112","author":"Ferber"},{"key":"10.1016\/j.jhepr.2024.101265_bib113","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1093\/jamia\/ocae133","article-title":"Fine-tuning large language models for rare disease concept normalization","volume":"31","author":"Wang","year":"2024","journal-title":"J\u00a0Am Med Inform Assoc"},{"key":"10.1016\/j.jhepr.2024.101265_bib114","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/MPG.0000000000001930","article-title":"Autoimmune hepatitis in children and adolescents: effect on quality of life","volume":"66","author":"De Carvalho","year":"2018","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhepr.2024.101265_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(23)03037-4","article-title":"The impact of a complete biochemical response on health-related quality of life in patients with autoimmune hepatitis: a multicentre prospective cross-sectional study","volume":"78","author":"Snijders","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2024.101265_bib116","doi-asserted-by":"crossref","first-page":"S712","DOI":"10.1016\/S0168-8278(24)02015-4","article-title":"WED-158-YI Disease experience and care expectations in european patients with immune-mediated liver disease","volume":"80","author":"Soret","year":"2024","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2024.101265_bib117","article-title":"Impact of patient programs on adherence and persistence in inflammatory and immunologic diseases: a meta-analysis","volume":"435","author":"Burudpakdee","year":"2015","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.jhepr.2024.101265_bib118","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/liv.15217","article-title":"Consensus recommendations for histological criteria of autoimmune hepatitis from the International AIH Pathology Group","volume":"42","author":"Lohse","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2024.101265_bib119","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1111\/liv.15971","article-title":"IAIH-PG consensus for histological criteria of AIH : multicentre validation with focus on chronic liver diseases in China","volume":"44","author":"Wang","year":"2024","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2024.101265_bib120","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1111\/liv.15394","article-title":"Recommendations for histological criteria of autoimmune hepatitis from the international AIH pathology: validation on a monocentric cohort","volume":"42","author":"Colapietro","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2024.101265_bib121","doi-asserted-by":"crossref","first-page":"100","DOI":"10.14744\/hf.2023.2023.0061","article-title":"Comparison of the recommendation of international autoimmune hepatitis pathology group 2022 and the simplified criteria for autoimmune hepatitis 2008: a preliminary study","volume":"5","author":"Moral","year":"2024","journal-title":"Hepatol Forum"},{"key":"10.1016\/j.jhepr.2024.101265_bib122","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3350\/cmh.2023.0325","article-title":"Comparison of four histological scoring systems for autoimmune hepatitis to improve diagnostic sensitivity","volume":"30","author":"Ahn","year":"2024","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jhepr.2024.101265_bib123","article-title":"Histological and serological features of acute liver injury after SARS-CoV-2 vaccination","author":"Codoni","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2024.101265_bib124","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/apt.16926","article-title":"Early predictors of corticosteroid response in acute severe autoimmune hepatitis: a nationwide multicenter study","volume":"56","author":"T\u00e9llez","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2024.101265_bib125","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.jhep.2020.12.033","article-title":"Early liver transplantation for corticosteroid non-responders with acute severe autoimmune hepatitis: the SURFASA score","volume":"74","author":"De Martin","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2024.101265_bib126","doi-asserted-by":"crossref","DOI":"10.1097\/HEP.0000000000000767","article-title":"NMR-based metabolomic signature: an important tool for the diagnosis and study of pathogenesis of autoimmune hepatitis","author":"Dimou","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2024.101265_bib127","article-title":"Circulating complement factor H levels are associated with disease severity and relapse in autoimmune hepatitis","volume":"4","author":"Hayashi","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2024.101265_bib128","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejim.2023.06.001","article-title":"Prevalence and significance of antimitochondrial antibodies in autoimmune hepatitis (AIH): results from a large multicentre study of the International AIH Group","volume":"116","author":"Gatselis","year":"2023","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jhepr.2024.101265_bib129","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/hep4.1889","article-title":"Noninvasive prediction of outcomes in autoimmune hepatitis\u2013related cirrhosis","volume":"6","author":"Llovet","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhepr.2024.101265_bib130","article-title":"Liver stiffness measurement predicts clinical outcomes in autoimmune hepatitis","volume":"101213","author":"Olivas","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2024.101265_bib131","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jhep.2023.09.010","article-title":"Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis","volume":"80","author":"Colapietro","year":"2024","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2024.101265_bib132","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jhep.2022.01.022","article-title":"Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation","volume":"77","author":"Montano-Loza","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2024.101265_bib133","article-title":"Mycophenolate mofetil as second line treatment in autoimmune hepatitis \u2013 a retrospective single center analysis","volume":"5","author":"Kolev","year":"2022","journal-title":"J\u00a0Transl Autoimmun"},{"key":"10.1016\/j.jhepr.2024.101265_bib134","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/hep4.1687","article-title":"Multiparametric magnetic resonance imaging, autoimmune hepatitis, and prediction of disease activity","volume":"5","author":"Arndtz","year":"2021","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhepr.2024.101265_bib135","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/liv.15583","article-title":"Right and left liver lobe biopsies by minilaparoscopy reveal clinically significant sampling error in staging and grading of autoimmune hepatitis","volume":"43","author":"Johannes","year":"2023","journal-title":"Liver Int"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555924002696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555924002696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T00:58:56Z","timestamp":1740877136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555924002696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":135,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S2589555924002696"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2024.101265","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quo vadis autoimmune hepatitis? - Summary of the 5th international autoimmune hepatitis group research workshop 2024","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2024.101265","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"101265"}}